Community-acquired pneumonia: Why aren't national antibiotic guidelines followed?

International Journal of Clinical Practice

Volumn 69, Issue 2, 2015, Pages 259-266

  Almatar, M A ^a   Peterson, G M ^a   Thompson, A ^a   McKenzie, D S ^b   Anderson, T L ^b  

^a UNIVERSITY OF TASMANIA   (Australia)

^b ROYAL HOBART HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZITHROMYCIN; CEFALEXIN; CEFAZOLIN; CEFOTAXIME; CEFTRIAXONE; CLARITHROMYCIN; DOXYCYCLINE; FLUCLOXACILLIN; GENTAMICIN; MOXIFLOXACIN; PENICILLIN G; ROXITHROMYCIN; TIMENTIN; ANTIINFECTIVE AGENT;

ADULT; AGED; ARTICLE; AUSTRALIA; AWARENESS; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; EMERGENCY WARD; FEMALE; FISHER EXACT TEST; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NONHUMAN; PATIENT COMPLIANCE; PHYSICIAN; PRACTICE GUIDELINE; PRESCRIPTION; QUESTIONNAIRE; RANK SUM TEST; RETROSPECTIVE STUDY; TEACHING HOSPITAL; TREATMENT RESPONSE; COMMUNITY-ACQUIRED INFECTIONS; MIDDLE AGED; PNEUMONIA; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; AUSTRALIA; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; GUIDELINE ADHERENCE; GUIDELINES AS TOPIC; HUMANS; MALE; MIDDLE AGED; PNEUMONIA; RETROSPECTIVE STUDIES; SURVEYS AND QUESTIONNAIRES;

EID: 84921777319     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/ijcp.12538     Document Type: Article

References (23)

1. Gall M, Krysiak K, Prescott V,. Asthma, Chronic Obstructive Pulmonary Disease and Other Respiratory Diseases in Australia. Canberra: Australian Institute of Health and Welfare, 2010.
2. Charles PGP, Wolfe R, Whitby M, et al. SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia. Clin Infect Dis 2008; 47: 375.
3. Skull S, Andrews R, Byrnes G, et al. Hospitalized community-acquired pneumonia in the elderly: an Australian case-cohort study. Epidemiol Infect 2009; 137: 194-202.
4. Capelastegui A, España PP, Quintana JM, et al. Improvement of process-of-care and outcomes after implementing a guideline for the management of community-acquired pneumonia: a controlled before-and-after design study. Clin Infect Dis 2004; 39: 955-63.
5. Blasi F, Iori I, Bulfoni A, et al. Can CAP guideline adherence improve patient outcome in internal medicine departments? Eur Respir J 2008; 32: 902.
6. Garau J, Baquero F, Pérez-Trallero E, et al. Factors impacting on length of stay and mortality of community-acquired pneumonia. Clin Microbiol Infect 2008; 14: 322-9.
7. Antibiotic Expert Group. Therapeutic Guidelines: Antibiotic. Melbourne: Therapeutic Guidelines Limited, 2010.
8. Rodrigo C, Mckeever TM, Woodhead M, Lim WS,. Single versus combination antibiotic therapy in adults hospitalised with community acquired pneumonia. Thorax 2013; 68: 493-5.
9. Cabana MD, Rand CS, Powe NR, et al. Why don't physicians follow clinical practice guidelines? J Am Med Assoc 1999; 282: 1458.
10. Maxwell DJ, McIntosh KA, Pulver LK, Easton KL,. Empiric management of community-acquired pneumonia in Australian emergency departments. Med J Aust 2005; 183: 520-4.
11. McIntosh KA, Maxwell DJ, Pulver LK, et al. A quality improvement initiative to improve adherence to national guidelines for empiric management of community-acquired pneumonia in emergency departments. Int J Qual Health Care 2011; 23: 142.
12. Buising KL, Thursky KA, Black JF, et al. Identifying severe community acquired pneumonia in the emergency department: a simple clinical prediction tool. Emerg Med Australas 2007; 19: 418-26.
13. Brett J, Lam V, Baysari MT, et al. Pneumonia severity scores and prescribing antibiotics for community-acquired pneumonia at an Australian hospital. J Pharm Pract Res 2013; 43: 97.
14. Lee RWW, Lindstrom ST,. A teaching hospital's experience applying the Pneumonia Severity Index and antibiotic guidelines in the management of community acquired pneumonia. Respirology 2007; 12: 754-8.
15. Rello J, Gattarello S, Souto J, et al. Community-acquired Legionella Pneumonia in the intensive care unit: impact on survival of combined antibiotic therapy. Medicina Intensiva 2012; 37: 320-6.
16. Charles PGP, Whitby M, Fuller AJ, et al. The Etiology of Community-Acquired Pneumonia in Australia: why Penicillin plus Doxycycline or a Macrolide Is the Most Appropriate Therapy. Clin Infect Dis 2008; 46: 1513-21.
17. Paterson DL,. "Collateral damage" from cephalosporin or quinolone antibiotic therapy. Clin Infect Dis 2004; 38: S341-5.
18. Lugtenberg M, Burgers J, Besters C, et al. Perceived barriers to guideline adherence: a survey among general practitioners. BMC Fam Pract 2011; 12: 98.
19. Linder JA, Schnipper JL, Tsurikova R, et al. Self-reported familiarity with acute respiratory infection guidelines and antibiotic prescribing in primary care. Int J Qual Health Care 2010; 22: 469.
20. Lim W, Baudouin S, George R, et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax 2009; 64: iii1.
21. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007; 44: S27.
22. Miyashita N, Kawai Y, Akaike H, et al. Clinical features and the role of atypical pathogens in nursing and healthcare-associated pneumonia (NHCAP): differences between a teaching university hospital and a community hospital. Intern Med 2012; 51: 585-94.
23. Moran GJ, Krishnadasan A, Gorwitz RJ, et al. Prevalence of methicillin-resistant staphylococcus aureus as an etiology of community-acquired pneumonia. Clin Infect Dis 2012; 54: 1126-33.